Serum Laminin And Syndecan -1: Novel Biomarkers In Predicting Liver Fibrosis Stage In Patients With Hepatocllular Carcinoma.

Essam Ali Mohamed;

Abstract


Hepatocellular carcinoma (HCC) is a major health problem worldwide, with more than 500,000 cases diagnosed annually and up to 80% of HCCs develop against a background of cirrhosis of the liver. Laminin is one of the main glycoproteins of the basement memb


Other data

Title Serum Laminin And Syndecan -1: Novel Biomarkers In Predicting Liver Fibrosis Stage In Patients With Hepatocllular Carcinoma.
Other Titles مستويات اللامينين و السينديكان-1 في مصل الدم: دلالات حيوية جديدة للتنبؤ بمراحل تليف الكبد في مرضى سرطان الكبد.
Authors Essam Ali Mohamed
Keywords Serum Laminin And Syndecan -1: Novel Biomarkers In Predicting Liver Fibrosis Stage In Patients With Hepatocllular Carcinoma.
Issue Date 2010
Description 
Hepatocellular carcinoma (HCC) is a major health problem worldwide, with more than 500,000 cases diagnosed annually and up to 80% of HCCs develop against a background of cirrhosis of the liver. Laminin is one of the main glycoproteins of the basement memb

Attached Files

File SizeFormat
100236r3729.pdf93.48 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.